Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 2.37%690.10 | 674.14 | 630.58 | 621.99 | 609.29 |
35.46%63.16 | 97.85 | 39.79 | - | - | |
| Research and Development | 35.46%63.16 | 97.85 | 39.79 | - | - |
| Costs And Expenses | 48.38%279.27 | 541.02 | 67.54 | 233.61 | 182.14 |
| Operating Income/Loss | 208.62%410.84 | 133.12 | 563.04 | 388.38 | 427.16 |
| Nonoperating Income/Loss | 179.28%-144.20 | -51.63 | -94.78 | -32.47 | 17.06 |
| Income/Loss From Equity Method Investments | 126.32%9.23 | 4.08 | 21.76 | 4.01 | 15.95 |
| Income/Loss From Continuing Operations Before Tax | 227.22%266.64 | 81.49 | 468.26 | 355.91 | 444.21 |
| Income Tax Expense/Benefit | - | - | - | - | - |
227.22%266.64 | 81.49 | 468.26 | 355.91 | 444.21 | |
| Attributable To Parent | 709.01%144.68 | 17.88 | 294.69 | 214.21 | 288.22 |
| Available To Common Stockholders, Basic | 709.01%144.68 | 17.88 | 294.69 | 214.21 | 288.22 |
| Attributable To Noncontrolling Interest | 91.76%121.96 | 63.60 | 173.57 | 141.71 | 155.99 |
| Basic Average Shares | 0.22%446.03 | 445.06 | 436.79 | -0.48 | 431.89 |
| Diluted Average Shares | 0.02%557.00 | 556.90 | 556.84 | -2.30 | 559.61 |
| Basic Earnings Per Share | 700.00%0.32 | 0.04 | 0.67 | 0.50 | 0.67 |
| Diluted Earnings Per Share | 700.00%0.32 | 0.04 | 0.67 | 0.50 | 0.67 |
| Common Stock Dividends | 0.24 | 0.24 | 0.24 | 0.22 | 0.22 |